Literature DB >> 21572372

Bacteremia in human immunodeficiency virus-infected children in Cape Town, South Africa.

David M le Roux1, Mark F Cotton, Stanzi M le Roux, Andrew Whitelaw, Carl J Lombard, Heather J Zar.   

Abstract

Bacteremia contributes to morbidity of HIV-infected children. In a randomized controlled trial evaluating trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, 47 bacteremias were detected. The incidence rate of bacteremia increased in the first 3 months after starting combination antiretroviral therapy (cART), but decreased by 74% once children were established on cART for more than 3 months. Children should be prioritized for early cART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572372     DOI: 10.1097/INF.0b013e318220a68b

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

1.  Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.

Authors:  Dhayendre Moodley; Leanne Reddy; Wisani Mahungo; Rebotile Masha
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

2.  Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children's hospital in Cape Town, South Africa.

Authors:  Reené Naidoo; James Nuttall; Andrew Whitelaw; Brian Eley
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

3.  Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.

Authors:  Lisa Frigati; Moherdran Archary; Helena Rabie; Martina Penazzato; Nathan Ford
Journal:  Clin Infect Dis       Date:  2018-03-04       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.